Mesoblast Limited (MSB):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61698FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Mesoblast Limited (Mesoblast) is a biotechnology company. The company focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. Its technology platforms include Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp Stem Cells (DPSCs) and Hematopoietic Stem Cells (HSCs). Mesoblast serves various therapeutic areas such as immunologic/ inflammatory, cardiac vascular, spine disease, ophthalmolog, neurologic and oncology. The company has partnership with Teva Pharmaceutical Industries Ltd., JCR Pharmaceuticals Co. Ltd. and Lonza Group. It has operational presence in the US and Singapore. Mesoblast is headquartered in Melbourne, Victoria, Australia.

Mesoblast Limited Key Recent Developments

Nov 25, 2013: New Japanese Regenerative Medicine Legislation and Commercial Opportunities for Stem Cell Products
Aug 29, 2013: Mesoblast’s Strong Cash Position Enables Execution of Late-Stage Clinical Trials
Jul 18, 2013: Mesoblast Receives $4.3 Million from Australian Government for Adult Stem Cell Pipeline Development
Jun 05, 2013: Mesoblast Obtains Key Japanese Patent Covering Mesenchymal Precursor Cells
Feb 13, 2013: Mesoblast Announces FDA Agreement On Its Use Of Singapore Manufacturing Facility For Clinical Trial Production Of Mesenchymal Precursor Cells

This comprehensive SWOT profile of Mesoblast Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mesoblast Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mesoblast Limited – Key Information
Mesoblast Limited – Overview
Mesoblast Limited – Key Employees
Mesoblast Limited – Key Employee Biographies
Mesoblast Limited – Key Operational Heads
Mesoblast Limited – Major Products and Services
Mesoblast Limited – History
Mesoblast Limited – Company Statement
Mesoblast Limited – Locations And Subsidiaries
Mesoblast Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mesoblast Limited – Business Description
Mesoblast Limited – Corporate Strategy
Mesoblast Limited – SWOT Analysis
SWOT Analysis – Overview
Mesoblast Limited – Strengths
Mesoblast Limited – Weaknesses
Mesoblast Limited – Opportunities
Mesoblast Limited – Threats
Mesoblast Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Mesoblast Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mesoblast Limited, Key Information
Mesoblast Limited, Key Ratios
Mesoblast Limited, Share Data
Mesoblast Limited, Major Products and Services
Mesoblast Limited, History
Mesoblast Limited, Key Employees
Mesoblast Limited, Key Employee Biographies
Mesoblast Limited, Key Operational Heads
Mesoblast Limited, Other Locations
Mesoblast Limited, Subsidiaries
Mesoblast Limited, Key Manufacturing facilities
Mesoblast Limited, Key Competitors
Mesoblast Limited, SWOT Analysis
Mesoblast Limited, Ratios based on current share price
Mesoblast Limited, Annual Ratios
Mesoblast Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Mesoblast Limited, Performance Chart
Mesoblast Limited, Ratio Charts

★海外企業調査レポート[Mesoblast Limited (MSB):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rajshree Sugars & Chemicals Limited (RAJSREESUG):企業財務及び戦略的SWOT分析
    Summary Rajshree Sugars & Chemicals Limited (RSCL) is a chemical company that offers sugar products. The company operates through its businesses in sugar, alcohol production, green power, and RSCL bio-products. Its activities include research and development for sustainable sugarcane cultivation, de …
  • TAG Oil, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TAG Oil, Ltd. Mergers and Acqui …
  • Vena Resources, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Vena Resources, Inc. Mergers an …
  • Logical Therapeutics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Logical Therapeutics, Inc. Merg …
  • Gedeon Richter Plc:戦略・SWOT・企業財務分析
    Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report Summary Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Solar Applied Materials Technology Corp. (1785):企業財務及び戦略的SWOT分析
    Summary Solar Applied Materials Technology Corp. (Solar) is a consumer packaged goods company that manufacturers optical data storage thin film. The company provides metal products and services for optoelectronics, petrochemicals and consumer electronics industries. Its products include sputtering t …
  • Hansa Medical AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hansa Medical AB Mergers and Ac …
  • Apogenix AG-製薬・医療分野:企業M&A・提携分析
    Summary Apogenix AG (Apogenix) is a biopharmaceutical company, developing immuno-oncology medicines for the treatment of cancer and other malignant diseases. Its pipeline drug candidates under clinical development include Asunercept (APG101), a CD95 ligand inhibitor, for the treatment of glioblastom …
  • Selex ES S.p.A(航空・防衛):企業概要、SWOT分析
    Summary Strategic Defence Intelligence's "Selex ES S.p.A: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business d …
  • Mitsubishi International Food Ingredients, Inc.:企業の戦略・SWOT・財務分析
    SummaryMitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ …
  • FluoroPharma Medical Inc (FPMI):企業のM&A・提携動向(医療機器分野)
    Summary FluoroPharma Medical Inc (FluoroPharma) is a laboratory equipment company that offers molecular imaging services. The company discovers, develops, and commercializes medical diagnostic imaging products. It develops breakthrough positron emission tomography imaging agents for the assessment a …
  • Orion Corporation:企業のM&A・提携・投資分析
    Orion Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Orion Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Edge Resources Inc. (EDE):企業のM&A・提携動向(石油・ガス分野)
    Summary Edge Resources Inc. (Edge Resources), formerly Guildhall Minerals Ltd is a mineral exploration company that focuses on the identification, acquisition and development of oil and gas exploration projects. The company’s projects include Eye Hill, Grand Forks and Edmonton Sands. Its Grand Forks …
  • OK Biotech Co. Ltd. (4155):(医療機器分野)企業M&A及び提携動向
    Summary OK Biotech Co. Ltd. (OK Biotech) is a medical device company. It manufactures and markets blood glucose monitoring devices and other related homecare medical products. The products that the company offers include nebulizer, blood glucose meter, glucometer, blood sugar meter and blood glucose …
  • Software Quality Systems AG (SQS):企業の財務及び戦略的SWOT分析
    Summary Software Quality Systems AG (SQS) is a technology company that provides software testing and quality management services. The company offers information technology services in project definition, development, final implementation, and in ongoing maintenance. Its services include quality and …
  • Electricity Supply Board-エネルギー分野:企業M&A・提携分析
    Summary Electricity Supply Board (ESB) owned by Irish Government, is a diversified and vertically integrated utility that generates, transmits, and distributes and supplies electricity and gas. The company builds, owns and maintains transmission and distribution networks. It offers meter reading, an …
  • GeoBio Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GeoBio Energy, Inc. Mergers and …
  • Investissement Quebec:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Investissement Quebec Mergers a …
  • Henan Huanghe Whirlwind Co., Ltd. (600172):企業概要、財務及び戦略的SWOT分析
    Summary Henan Huanghe Whirlwind Co., Ltd. (Henan Huanghe) is a synthetic diamond manufacturer. The company conducts research, and manufactures and trades synthetic diamond and diamond tools. It operates through its various product divisions such as super-hard materials and manufacturing, diamond too …
  • Implanet S.A. (IMPL):企業財務及び戦略的SWOT分析
    Summary Implanet S.A. (Implanet) is a medical device company that designs, manufactures and markets orthopedic implants. The company offers spine, knee and arthroscopy products. It offers resorbable anchors system; ligament anchor; buttons for femoral fixation; resorbable interference screws; poster …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆